Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Veru Inc. is a biopharmaceutical company focused on developing and commercializing medicines for metabolic diseases, oncology, and ARDS. Its core assets include late-stage drug candidates enobosarm and sabizabulin, targeting obesity, breast cancer, and viral-induced lung injury. The company also markets the FDA-approved FC2 Female Condom, serving global sexual health markets and public health sectors. Its business model combines drug development, clinical trials, and health product sales.
This description was generated via AI from an annual report. Updated about 1 year ago.